Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

NCT04598009 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Stage III
Melanoma Stage IV

Interventions

DRUG: Binimetinib
DRUG: Imatinib

Sponsor

University of California, San Francisco

Collaborators

[object Object]